Samarium Sm 153 lexidronam for the palliative treatment of dogs with primary bone tumors: 35 cases (1999-2005).

@article{Barnard2007SamariumS1,
  title={Samarium Sm 153 lexidronam for the palliative treatment of dogs with primary bone tumors: 35 cases (1999-2005).},
  author={Sandra M Barnard and Richard M Zuber and Antony S. Moore},
  journal={Journal of the American Veterinary Medical Association},
  year={2007},
  volume={230 12},
  pages={1877-81}
}
OBJECTIVE To evaluate survival times and palliative effects associated with the use of samarium Sm 153 lexidronam in dogs with primary bone tumors. DESIGN Retrospective case series. ANIMALS 35 dogs with primary appendicular (n = 32) or axial (3) bone tumors. PROCEDURES 1 to 4 doses of samarium Sm 153 lexidronam were administered at a rate of 37 MBq/kg (16.8 MBq/lb), IV. Response to treatment, measured by lameness improvement, and survival time were determined. RESULTS Of the 32 dogs… CONTINUE READING

From This Paper

Topics from this paper.
3 Citations
0 References
Similar Papers